U.S. Senator Jacky Rosen announced that 15 additional medications have been selected for Medicare drug pricing negotiations, ...
Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin ... (CMS), announced that 15 new drugs that are currently covered under Medicare Part D will be selected for ...
The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...
New AARP Report Finds Medicare Part D Enrollees Who Reach the New $2,000 Out-of-Pocket Spending Cap Will Save Thousands ...
The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback